Ultrastructural analysis of edelfosine-treated trypomastigotes and amastigotes of Trypanosoma cruzi
- 90 Downloads
We have previously reported that epimastigote forms of Trypanosoma cruzi treated with the lysophospholipid analogues (LPAs) edelfosine (ET-18), ilmofosine, and miltefosine suffered alterations in plasma membrane, mitochondrion, and lipid synthesis. In this work, ET-18 induced membrane damage in trypomastigotes and amastigotes. Incubation of epimastigotes and trypomastigotes with the three LPAs led to membrane permeabilization, which was abolished by serum addition. Treatment for 24 h in culture medium interfered the with mitochondrial status of epimastigotes, with no effect in trypomastigotes, in agreement with ultrastructural data. LPAs induced alterations in the plasma membrane of the three forms of T. cruzi and in the mitochondria of epimastigotes, suggesting that these organelles are potential targets of these analogues.
We are grateful to Dr. Maurilio J. Soares for the critical reading of this manuscript and for facilitating helpful discussions. This work was sponsored by CNPq, Faperj and Fiocruz.
- Coura JR, De Castro SL (2002) A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 97:3–24Google Scholar
- De Castro SL, Santa-Rita RM, Urbina JA, Croft SL (2004) Antiprotozoal lysophospholipid analogues: a comparison of their activity against trypanosomatid parasites and tumour cells. Mini Rev Med Chem 4:139–148Google Scholar
- Lira R, Contreras LM, Rita RM, Urbina JA (2001) Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: potentiation of in vitro activity by the sterol biosynthesis inhibitor ketoconazole. J Antimicrob Chemother 47:537–546PubMedCrossRefGoogle Scholar
- Santa-Rita RM, Lira R, Barbosa HS, Urbina JA, De Castro SL (2005) Anti-proliferative synergism of lysophospholipid analogues and ketoconazole against Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae): cellular and ultrastructural analysis. J Antimicrob Chemother 55:780–784PubMedCrossRefGoogle Scholar
- Saraiva VB, Gibaldi D, Previato JO, Mendonça-Previato L, Bozza MT, Freire-de-Lima CG, Heise N (2002) Proinflammatory and cytotoxic effects of hexadecylphosphocholine (Miltefosine) against drug-resistant strains of Trypanosoma cruzi. Antimicrob Agents Chemother 46:3472–3477PubMedCrossRefGoogle Scholar
- WHO (1997) Chagas disease. Thirteenth programme report UNDP/WB/TDR Geneve, pp 112–123Google Scholar